Cortexyme is betting that an infectious agent causes Alzheimer’s, and that targeting that pathogen can stop and even reverse the disease.
STAT takes a closer look at the most closely followed biotech companies, rounding up answers to some of our earlier questions and posing some new ones.
The effort is one more sign of the desperation in major metropolitan areas to ramp up testing for the coronavirus, called SARS-CoV-2.
The encouraging data offer hope that genome editing might one day offer a safe, durable cure for sickle cell disease and beta thalassemia.
If the iconoclasts are right, putting coronavirus patients on ventilators could be of little benefit to many and even harmful to some.
The promise of health AI comes with the humility that those who develop health algorithms have learned: algorithms are only as good as the data that go into them and the humans who interpret the…
«During my career, I have spent time on each side. Now, as the CEO of a company on the border, I’ve developed a deeper understanding of the differences that create barriers to mutual innovation. For health AI to achieve its potential, health care and tech companies must keep the big picture top of mind: health care is about saving lives.»
In an ‘historic’ first, scientists freeze, thaw, and transplant rat organs — bringing transplant medicine one step closer to sci-fi dreams of stopping biological time.
Maithra Raghu, a research scientist at Google Brain, is betting that neural networks can become a powerful tool in medicine.
The way we are dealing with mental health problems at the moment is very clearly not working.
Technology can improve how to care for people with mental illness; it just can't replace actual care. And when it comes to care, you get what you pay for.
Researchers believe that neurology will soon be comfortable incorporating brain stimulation into routine care, just as cardiology has accepted electrical devices such as pacemakers and defibrillators…
In a secret experiment, researchers replaced the dysfunctional brain cells of a Parkinson’s patient with the progeny of an extraordinary type of stem cell.
This is "biology's century," @matthewherper writes. But we’re approaching a moment when changes in what we understand are every bit as terrifying as exhilarating.
Where things stand now with the pandemic, and who is being hurt the most, as the country prepares to enter its third Covid autumn.
The FDA authorized new Covid booster shots from Moderna and Pfizer that more closely match the strains of the coronavirus that are currently circulating in the U.S.
More than two years after SARS-CoV-2 appeared, there are still many mysteries about the virus and the pandemic it caused. STAT examined six key mysteries that scientists are beginning to unravel.
Renaming monkeypox — the virus and the disease — is proving more challenging than some expected.
Here are some of the things we have learned about Covid-19, and some of the pressing questions that we still need answered.
How does Refind curate?
It’s a mix of human and algorithmic curation, following a number of steps:
- We monitor 10k+ sources and 1k+ thought leaders on hundreds of topics—publications, blogs, news sites, newsletters, Substack, Medium, Twitter, etc.
- In addition, our users save links from around the web using our Save buttons and our extensions.
- Our algorithm processes 100k+ new links every day and uses external signals to find the most relevant ones, focusing on timeless pieces.
- Our community of active users gets the most relevant links every day, tailored to their interests. They provide feedback via implicit and explicit signals: open, read, listen, share, mark as read, read later, «More/less like this», etc.
- Our algorithm uses these internal signals to refine the selection.
- In addition, we have expert curators who manually curate niche topics.
The result: lists of the best and most useful articles on hundreds of topics.
How does Refind detect «timeless» pieces?
We focus on pieces with long shelf-lives—not news. We determine «timelessness» via a number of metrics, for example, the consumption pattern of links over time.
How many sources does Refind monitor?
We monitor 10k+ content sources on hundreds of topics—publications, blogs, news sites, newsletters, Substack, Medium, Twitter, etc.
Can I submit a link?
Indirectly, by using Refind and saving links from outside (e.g., via our extensions).
How can I report a problem?
When you’re logged-in, you can flag any link via the «More» (...) menu. You can also report problems via email to email@example.com
Who uses Refind?
250k+ smart people start their day with Refind. To learn something new. To get inspired. To move forward. Our apps have a 4.9/5 rating.
Is Refind free?
Yes, it’s free!
How can I sign up?
Head over to our homepage and sign up by email or with your Twitter or Google account.